Community/Retail

A health-system pharmacist was recently let go after peeking at the health records of patients not in his care.

Vitamin D insufficiency may raise the odds of depressive symptoms in college-aged women.

Tighter hydrocodone regulations meant to reduce opioid abuse are hindering pain patients' access to the products.

The FDA's advisory committee supports the approval of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma in only adults.

As Homer's hero, Odysseus, once advised, "There is a time for many words, and there is a time for sleep."

This interview features Adma Metcalf, PharmD, of Hill Country Apothecary.

Patients with healthy diets may be more likely to use supplements.

The FDA is warning health care professionals and patients about OTC asthma products labeled as homeopathic remedies.

MOVANTIK is a first-in-class, once-daily, oral, peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

The agreement creates possible new treatment options for cancer patients.

A pharmacy school team nabbed second place in the Mississippi Public Universities' Blueprint Mississippi Social Business Challenge.

Stories on drug manufacturers' patent-protection strategies suggest that the high costs of some drugs are receiving attention from other health care team members, as well as government officials.

The Virginia Commonwealth University School of Pharmacy dean's advice for graduating students is to think about what employers are looking for when they hire pharmacists.

Now in its sixth year, the annual program recognizes outstanding pharmacists, technicians, student pharmacists and industry advocates.

Seniors with dementia who take antipsychotics may face a higher risk of death than previously thought.

Prior to dispensing a prescription to a patient, it may pay to walk a mile in his or her shoes.

Development planned for multiple autoimmune diseases, including rheumatoid arthritis and lupus.

The investigational anti-thrombin antibody ichorcumab strengthens Janssen's cardiovascular disease portfolio.

The award recognizes substantive, positive contributions to the herbal products industry.

The 2 women most involved in my life are now patients of mine outside of my pharmacy practice.

FDA laboratory analysis has confirmed that 3 products promoted as weight-loss supplements contain hidden drug ingredients with known risks.

A pharmacist involved in a Medicare scheme has pleaded guilty to health care fraud.

Living alone and feelings of isolation and loneliness were associated with an increased risk for early death in a new study, which was published in Perspectives on Psychological Science.

Marijuana has been used for medicinal purposes for more than 3000 years.

In response to a recent resurgence in fentanyl abuse, the DEA issued a nationwide alert about the dangers of the drug, describing it as a threat to health and public safety.

Bipartisan legislation to improve access to medication therapy management (MTM) services for senior citizens enrolled in the Medicare program received a nod from the National Association of Chain Drug Stores.

Pharmacists and other health care providers often do not advise patients with mental illness symptoms and diabetes to make lifestyle changes that would reduce related health risks.

The bipartisan legislation would expand access to medication therapy management services for Medicare beneficiaries.

Women who smoke during pregnancy may be putting their children at risk for developing diabetes in adulthood.

As the US Centers for Medicare and Medicaid Services places a greater emphasis on medication adherence through its star ratings, pharmacists and other health care professionals continue to seek ways to improve adherence among seniors.